Want to join the conversation?
Pharmaceutical company $AKRX said it received a notice from the Nasdaq Listing Qualifications Staff stating non-compliance with Nasdaq Listing Rule 5250(c)(1) because the company did not file its Form 10-K for the year ended Dec. 31, 2015 with the SEC by Feb. 29, 2016. $AKRX aims to file the necessary periodic reports by the May 9, 2016 extension.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.